Coimbra Institute for Biomedical Imaging and Translational Research

Technology transfer

Focus on Medical Device and Radiopharmaceutical Clinical Validation Platforms.
To promote technology transfer of molecular imaging approaches.
We manage several national infrastructures with research agreements with companies.
Biomarker validation tests for clinical applications (validation of multivariate markers, by developing distinct software modules), neurorehabilitation software/hardware.
Prototype for molecular imaging in animals.
Investigator driven trials approved in the fields of medical devices and radiopharmaceuticals

Industry both in which concerns R&D (IBA, Siemens, Icnas-Produção) and Clinical trials (Biogen, Roche, Merck, PPDA, and others).
Investigator driven trials approved in the fields of Medical Devices (EU projects STIPED and BRAINTRAIN) and Radipharmaceuticals.
Spinning off activities (PetSys and LIP for development of a new PET scanners for animals and humans).

Process for producing Gallium-68 through the irradiation of a solution target. A Abrunhosa, V Alves, F Alves. US Patent App. US20190013108A1. Submited. 2019.
Non-invasive system for measuring the arterial input function for PET imaging. Caramelo, F. et al. International Patent App. WO2018150348. Submited. 2018.
Process for producing gallium-68 through the irradiation of a solution target. VH Alves, F Alves and AJ Abrunhosa. EP3101660A1. Accepted 09/08/2017
Bernardes et al. have a European patent on statistical classifiers applied to optical coherence data as biomarkers for central neurodegenerative disorders.
P2020-PTDC/CTM-NAN/2658/2014 (POCI-01-0145-FEDER-016648), Dual nanostructured lipid carriers as a multifunctional platform for brain tumor therapy (submitted)
BrainEyes – A new method to test colour vision with low cost hardware for glaucoma diagnosis.